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Background: The molecular mechanisms and overt effects of nanoparticle-induced changes in 
red blood cells (RBCs) structure and function across membrane cell lines remain unclear 
despite the increasing use and application in nanomedicine. The aim of this study  was   to 
assess the  impact of nanosilver exposure  on osmoregulation of  red cell membrane fragility in 
digoxin-induced Na+-K+ATPase blockade in vitro. Materials and Method: Samples from 50 
subjects were obtained from consenting asymptomatic adults: male and female HbAA 
haemoglobin genotype. After separation and washing of erythrocytes, the samples were 
divided into three sets with each sample treated in duplicate with graded percentage 
concentrations of phosphate buffer solutions (0.9, 0.8, 0.7, 0.6, 0.5, 0.4, 0.3, 0.2, and 0.1). The 
second and third set of samples were incubated with 0.05ml of erythrocytes, 1 ml phosphate 
buffer saline and 1 ml nanosilver or digoxin of 25 mg/ml. Thereafter, the content of each test 
tube was incubated for 1 hour and 3 hours respectively. The absorbance was recorded after 
30mins incubation for each set with standard spectrophotometer at 540 nm wavelength. 
Haemolysis in each tube was recorded and expressed as percentage of the absorbance in 
distilled water. The average values recorded were plotted against the different concentrations 
used.  Results: Erythrocytes from the sample incubated with nanosilver had significantly 
increased osmotic lysis compared with the untreated cells in rate-depended manner (P<0.05). 
Similar pattern was observed with digoxin pre-incubated cells. The mean osmotic fragility 
(MOF) index of the untreated, nanosilver and digoxin pre-incubated cells was in the order: 
digoxin>nanosilver>untreated. Conclusion: exposure of RBCs to nanosilver and in 
Na+/K+ATPase blockade may result in increased hemolytic effects by multifactorial cell 
membrane-mediated processes 
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INTRODUCTION   
 Nanotechnology is the control and restructuring of 
matter at the nanoscale to atomic and molecular size 
range of about 1-100nm, in order to create materials, 
devices, and systems with fundamentally new 
properties and functions (Yuan et al., 2017, Sanam et 
al., 2021). Nanoscience is broad based, and the 
application of nanotechnology integrates 
multidisciplinary fields including material engineering, 
information high-tech, biogenetics and biomedical 
sciences and innovative commercial consumer 
products. 
Owing to their small size physicochemical unique and 
probiotic properties with proven wide range of 
biomedical health benefits and potentials, especially in 
treatment of cancer, HIV and other related viral and 
bacterial diseases, there has been a sudden upsurge 
recently in nanomaterial use and applications (Larisa et 
al., 2020). 
 Among several known nanomaterials of diverse 
structures, size and morphology, nanosilver (NS) is 
most commonly used nanoparticles. Nanosilver   are 
heterogeneous particles of silver between 1nm and 
100nm in size (Ghaffari and Hamedi, 2015) and has 
been used in medicine for centuries on   account of  its 
high antimicrobial  properties. (Adriana et al., 2020).  
Because of their large surface area-to-volume ratios, 
nanosilver offers a large antimicrobial spectrum and 
greater efficacy against bacteria than common 
antibiotics and provides new opportunities for use in 
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both consumer and biomedical applications, making 
them most commercialised nanoparticles (NPs) 
(Mohanty et al., 2012 and Abirami et al., 2017, 
Mousumi et al., 2020).  Nanosilver reach the blood 
stream through different routes of application and  is 
distributed  to organs including liver, kidney and brain 
(Daniel et al., 2018).  RBCs are also responsible for 
carriage of respiratory gases for cellular metabolism 
and energy production. In the clinical, NS coat 
cardiovascular and neurosurgical catheters, surgical 
instruments, wound and burn dressings and bone 
substitute biomaterials (Li  et al., 2015). 
Nanoparticles are reported to induce toxicity in 
biological cell organs due to adherence of particles to 
cell membrane. The release of silver ions (Ag+) in the 
medium due to oxidation of the Ag NPs imposes 
cytotoxicity, genotoxicity, and apoptosis (Mousumi et 
al., 2020). Erythrocytes transmembrane transport is 
essentially mediated by Na+/K+ATPase (NKA) which is 
an integral membrane protein that spans the red cell 
membrane. The main function of the NKA is to 
regulate osmotic pressure. The main factors related to 
osmotic pressure are H2O the concentration of ions and 
bioorganic molecules. Significant alterations in the 
extracellular ionic concentrations activates perpetual 
ion pump activity to maintain the cytosolic 
concentrations, which are important for numerous 
cellular enzymatic functions and regulations. Inhibition 
of NKA enzyme activity in gills; alterations in 
concentrations of plasma biochemicals (electrolytes, 
proteins, lipids), oxidative stress/cell damage markers 
and histopathological changes are among other 
deleterious effects of exposure to different sublethal 
concentrations of Ag-NPs LC50 (96h) in fish (Vali et 
al., 2020). The affinity of NKA for sodium and 
potassium seems to be modulated by tissue-specific 
factors, such as the lipid composition of the membrane, 
ionic composition and pH (Juliana et al., 2020 ) and 
activities of cardiac glycosides like ouabain and 
digoxin are known to inhibit NKA accompanied by an 
increase in cell volume and osmotic fragility and a 
decrease in the cytosolic K+/Na+ ratio (Kowluru et al., 
1989). It has been postulated that nanoparticle toxicity 
is increased by the adherence of nanoparticles (NPS) to 
cell membrane. The biocompatibility and toxicity of 
NPS have been widely studied and data from different 
nanomaterials in different cell lines and animal 
experimental models present conflicting reports and the 
molecular mechanisms and factors influencing NPS 
toxicity are still enigma. Therefore, in view of the 
increase in application, the biosafety and the 
mechanism by which NPS act at different levels of 
biological systems and cellular organs accumulation as 
well as environmental exposures have attracted much 
attention and become subject of great concern recently 
in nanotechnology investigations.  
Functionally, osmotic fragility is widely used to 
determine erythrocyte integrity and elucidate 
mechanisms of the influence of different factors on the 
osmotic properties of RBC membranes, including shear 
stress and mechanical haemolysis, temperature, 
ultrasound effects, drugs and irradiation (Laloy et 
al.,2014, Tomasz et al.,2014).  Osmotic fragility   is a 
useful indicator for evaluating the interactions of 
various substances with the red cell membrane in vitro.   
The aim of the present study was to examine the 
influence of RBC exposure to nanosilver and 
Na+/K+ATPase regulatory activity on erythrocyte 
membrane osmotic fragility responses in RBCs from 
HBAA subjects following digoxin inhibition. 
 
MATERIALS AND METHODS 
Subjects: 
Blood sample was collected from 50 consenting 
individuals of HbAA haemoglobin genotype 
erythrocytes, Both male and female apparently healthy 
asymptomatic subjects within 18-25 years participated 
in the study after informed consent was obtained.  
 
Phosphate buffer solution: 
Phosphate buffer of the following composition (mL): 
NaCl/ 8.0g KCl/0.2g  Na2HPO4/1.42g   KH2HPO4/ 
0.24g with  a  pH  of  7.4 . From this phosphate buffer 
solution, different osmolarities (0.9, 0.8, 0.7, 0.6, 0.5, 




Five millilitres (5 ml) of blood were collected from 
each subject into a lithium heparin anticoagulant bottles 
and analyzed within 2 hrs of collection. Blood was 
centrifuged at 2500 rpm for 10 minutes in order to 
separate the erythrocytes from plasma.The erythrocytes 
were washed three times by methods as described by 
Tsakiris  et al., 2005 with 5ml of 0.9 Phosphate buffer 
saline. Thereafter, erythrocytes were re-suspended in 
3ml of phosphate buffer saline and the test carried out 
with these washed and intact erythrocytes. 
 
Fragility experimental protocols 
The blood samples were divided into three sets, with 
each sample set treated in triplicate with graded 
percentage of phosphate  buffer solutions (0.9, 0.8, 0.7, 
0.6, 0.5, 0.4, 0.3, 0.2, and 0.1) as control to assess their 
resistivity to osmotic stress and thereafter, the second 
set of  test tubes, 0.05ml of blood, 1 ml  phosphate 
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buffer saline and 1 ml nanosilver. The third set of test 
tubes contained 0.05 ml of blood, 1 ml phosphate 
buffer saline and 1 ml digoxin of 25mg/ml.  The 
content of each test tube was incubated for 1 hour and 3 
hours respectively as described by Dacie and Lewis, 
1995; at room temperature 370C after which it was 
centrifuged at 2500 revolution per minute (RPM) for 10 
minutes.   The supernatant of the spun mixture was 
extracted, and optical absorbance was recorded with a 
standard spectrophotometer at 540nm wavelength. 
Haemolysis in each tube was expressed as a percentage 
of the absorbance in distilled water. The average values 
recorded were plotted against different concentrations 
used. 
 
Evaluation of fragility index and stabilization of 
erythrocytes:  
Mean osmotic fragility (MOF) (concentration of the 
solution when 50% of the cells are haemolysed) was 
graphically determined. While the relative capacity to 
stabilize or destabilize erythrocyte membrane was 
evaluated as percentage of quotient of the difference 
between MOF values of the test and control samples to 




Data analyses were done with GraphPad prism 5.0 
Statistical software, followed by one-way  analysis of 
variance (ANOVA). Values are presented as means ± 
SEM.  P-values less than 0.05 (p<0.05) were 
considered statistically significant, while n-values 
denote number of animals in each experimental group. 
 
RESULTS 
In the Osmotic fragility curves of erythrocytes 
following 1hour and 3 hours incubation in nanosilver in 
vitro (Fig. 1), there was a significant (p<0.05) increase 
in haemolysis by a right-ward shift of the curves with 
nanosilver treated cells compared with the untreated 
samples. This indicates decrease in osmotic burst 
resistance. 
As shown in fig. 2 of hemolysate curves from cells pre-
incubated with digoxin (Na+/K+ATPase) inhibitor and 
thereafter, following exposure to 10ppm nanosilver in 
vitro at 370C in 1hour and 3 hours incubation 
respectively. There was a right-ward shift of the curves 
with digoxin pre-treated cells compared with the 




Fig.1: Nanosilver-induced haemolysis during 1 hr and 
3 hrs incubation.  
 
 
Fig. 2:  Fragility response curves during 1 hr and 3 hrs 
nanosilver exposure in digoxin pre-incubated erythrocytes. 
 
In fig. 3 is the Comparative composite osmotic fragility 
curves of red cells treated with nanosilver and pre-
incubated with digoxin for 1 hour and 3 hours 
respectively. The significant increase in red cell lysis 
by right-ward shift of the hemolysate curves with 
digoxin pre-incubated cells and nanosilver treated cells 
compared with the control indicate decrease in osmotic 
burst resistance. The degree of lysis in rate in the 
treated cells was in the order: 3hours>1 hour. Mean 
osmotic fragility (MOF) (concentration of the 
solution when 50% of the cells are haemolysed) 
(0.38, 0.36 and 0.32) g/dl was in the order: 
digoxin>nanosilver>untreated, suggesting an 
increase in osmotic fragility in treated cells. 
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Fig. 3: Comparative effects of nanosilver-induced 
haemolysis during 1 hr and 3 hrs incubation in digoxin 
which inhibits Na+/K+ATPase. 
 
The tenet was the same in relative capacity to stabilize 
or destabilize erythrocyte membrane evaluated as 
percentage of quotient of the difference between MOF 
values of the test and control samples. 
 
DISCUSSION 
The blood stream is the principal transport system for 
delivery of organic and non-organic substances 
including nutrients, biomolecules, respiratory gases, 
electrolytes and other biomaterials such as 
nanoparticles to target organ sites.  Owing to the 
increasing importance and wide applications of 
nanomaterials in the advancement and improvement in 
healthcare service delivery in nanomedicine, 
biosystems, engineering and other industrial consumer 
products, focus on identification of cytotoxic effects 
associated with their use and applications has become 
imperative to guarantee biocompatibility within 
physiological systems. safe and sustainable 
development of nanotechnology for responsible and 
effective management of its potentials and safety 
concerns of patients and other end users. The 
haemolytic properties and interactions  with  red  blood 
cells to ascertain the level of toxicity or undesirable 
effects are the main parameters for the 
hemocompatibility in nanotechnology.  
The osmotic fragility evaluation is employed to 
measure the erythrocyte resistance to haemolysis 
following exposure to varying hypotonic concentrations 
of NaCl solution. Na+/K+ATPase plays an important 
role in the regulation of cellular Na+ and K+ 
concentrations and is one of the key enzymes 
responsible for maintaining the osmotic balance of cell 
and transmission of action potentials (Dao-Sheng et al., 
1990).  The present study therefore examined the  
impact of 10ppm size nanosilver exposure  on 
Osmoregulation of  red cell membrane resistivity on 
fragility responses in digoxin-induced Na+/K+ATPase 
blockade in vitro. The data obtained from this study 
indicate an increase in osmotic lysis demonstrated by 
the rightward shifts of the fragility curves from the red 
cells pre-incubated with digoxin for one hour and three 
hours respectively and exposed to nanosilver compared 
with the untreated cell. The increase in fragility 
response was greater during the three hours exposure in 
both treated cells. This suggests rate-dependent 
nanosilver-induced decrease in erythrocyte burst 
resistance. The observation of nanosilver-induced 
hemolytic effect is in concordance with the work of 
Abirami et al., 2017 who reported increase nanosilver 
haemolytic effects in fish and aquatic organisms. 
Furthermore, the mean osmotic fragility index (MOF) 
(concentration of the solution when 50% of the cells are 
haemolysed) obtained from the two different test 
samples compared with the control was in the order: 
digoxin>nanosilver>untreated, suggesting an 
enhancement in nanosilver-induced hemolytic action 
during Na+/K+ATPase blockade by digoxin. MOF is a 
measure of the osmotic fragility (OF) parameter 
(Dewey et al., 1982, Krogmeier et al., 1993). In clinical 
practice, osmotic fragility test is often done to aid  with 
diagnosis of diseases associated with RBC membrane 
abnormalities. Some disease conditions linked to 
increased osmotic fragility include hereditary 
spherocytosis and hypernatremia, while some linked to 
decreased fragility include chronic liver disease, iron 
deficiency anaemia, thalassemia, polycythemia vera, 
and sickle cell anaemia after splenectomy (Ajayi and 
Igwilo, 2016). The mechanism of action associated 
with nanosilver-induced increase in red cell fragility 
and other cell line reported toxicity has not been fully 
characterised. From previous findings, the decrease in 
osmotic burst resistance following exposure to 
nanosilver could be associated with the unique small 
size and physiochemical properties of nanosilver 
particles which enhance rapid direct membrane 
increased permeability across cells (Andriana et al., 
2020). It has also been alluded that in vitro and in vivo 
animal models nanosilver particles non-covalently 
attached to red blood cells surfaces via electrostatic 
force attraction due to the presence of negatively 
charged proteins, lipids and polysaccharides on 
mammalian cells which offer a range of functional 
groups and surface properties that permit the 
attachment of cationic nanoparticles to their surface 
(Anselmo et al., 2013, Daniel et al., 2018). 
Additionally, in vitro experiments have shown that 
cardiac glycosides including ouabain and digoxin 
inhibit the sodium pump of the red cell. The 
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physiological consequences of inhibiting 
Na+/K+ATPase may result in alteration in homeostasis 
of the red cell membrane in regulation of cell volume.  
The effect of digoxin-induced Na+/K+ATPase blockade 
would result in a reduction of the intracellular 
potassium and an increase in intracellular sodium 
content with concomitant increase in cell volume and 
ultimately increase in cell lysis; since sodium efflux is 
actively coupled to potassium influx at the cell 
membrane. In normal cell membrane function in 
biological systems, Na+/K+ATPase sodium-potassium 
sustained concentration gradient is crucial for 
physiological processes in many organs and has an 
ongoing role in stabilizing the resting membrane 
potential of the cell, regulation of the cell volume and 
in the cell signal transduction (Pirahanchi et al., 2021). 
In conclusion, exposure of RBCs to nanosilver and 
Na+/K+ATPase blockade may result in increase 
hemolytic effects by multifactorial cell membrane-
mediated processes. 
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